Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Members of the Oxford and Thames Valley MDS Patient Support Group, which provides support to those affected by Myelodysplastic Syndromes, visited the MRC Weatherall Institute of Molecular Medicine (WIMM) on Friday 29 September.

The visit was hosted by Dr Lynn Quek and members of Prof Paresh Vyas' research team at the MRC Molecular Hematology Unit, who are members of the Radcliffe Department of Medicine. Their research is supported by the NIHR Oxford Biomedical Research Centre.

The visit started with a series of short presentations on current research in haematological cancers at the MRC WIMM, including efforts to improve patient care and recent advances in genomics and stem cell biology. This was followed by a lively question and answer session, and a tour of research facilities.

Nurse Kirsty Corzier, who leads the patient group said: “These visits are vital in helping patients/relatives fully understand, feel informed and appreciate where advances come from in relation to their disease, even if they are not yet feeling their direct impact”.

Feedback from the visit was very positive. “The best part for me was undoubtedly the input from Dr Quek and her colleagues, which fascinated both my daughter and me”, said one of the patients “We talked of little else for the rest of the day and still do! The laboratory visit was also most interesting.”

The researchers involved also benefited greatly from this experience. As Dr Quek explained, “visits such as these are also an opportunity for research scientists to exchange ideas with patients and involve them in the process”.

Similar stories

New Studentship honours Enzo Cerundolo

A new Studentship has been announced in memory of the late MRC HIU Director and MRC WIMM Group Leader.

2022 RDM Graduate Prize Winners

This year's RDM winners are Edward Jenkins, Antje Rottner, and Akshay Shah.

Nucleome Therapeutics raises oversubscribed £37.5 million Series A financing

The biotechnology company builds upon research conducted by Professor Jim Hughes and Prof. James Davies at the MRC Weatherall Institute of Molecular Medicine, and combines 3D genome technology and machine learning to decode the dark matter of the human genome.

KJ Patel appointed new Chief Scientist of CRUK

Alongside his new role at Cancer Research UK, Prof. Patel will continue as the Director of both the MRC Weatherall Institute for Molecular Medicine (MRC WIMM) and the MRC Molecular Haematology Unit (MRC MHU).

September is Childhood Cancer Awareness Month

September is Childhood Cancer Awareness Month, where our Childhood Leukaemia research group have taken action to help raise awareness for this cause.